chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Hypokinesia, Muscle strength abnormal
Clinical narrative: I couldn't lift a cup of coffee. When I wake up I can hardly move; loss of muscle strength/ It's like I've lost my muscle strength. It's like I've done a heavy workout far beyond the point that I should do one; This spontaneous case was reported by a consumer and describes the occurrence of HYPOKINESIA (I couldn't lift a cup of coffee. When I wake up I can hardly move) and MUSCLE STRENGTH ABNORMAL (loss of muscle strength/ It's like I've lost my muscle strength. It's like I've done a heavy workout far beyond the point that I should do one) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 013M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FENOFIBRATE, RAMIPRIL, LEVOTHYROXINE SODIUM (LEVOTHYROXIN), CHLORPHENAMINE MALEATE, HYDROCODONE BITARTRATE, PHENYLEPHRINE HYDROCHLORIDE (TRIANT-HC) and METHOTREXATE for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021 at 10:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced HYPOKINESIA (I couldn't lift a cup of coffee. When I wake up I can hardly move) and MUSCLE STRENGTH ABNORMAL (loss of muscle strength/ It's like I've lost my muscle strength. It's like I've done a heavy workout far beyond the point that I should do one). At the time of the report, HYPOKINESIA (I couldn't lift a cup of coffee. When I wake up I can hardly move) and MUSCLE STRENGTH ABNORMAL (loss of muscle strength/ It's like I've lost my muscle strength. It's like I've done a heavy workout far beyond the point that I should do one) had not resolved.            No treatment information was provided.   This case was linked to MOD-2021-075434 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Added patient details and concomitant medications. Updated the events outcome.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: needed to re take second dose as punctured vial was open for more than six hours; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (needed to re take second dose as punctured vial was open for more than six hours) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (The patient did not have any chronic or long standing health conditions.).   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Feb-2021 at 10:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (needed to re take second dose as punctured vial was open for more than six hours). On 17-Feb-2021 at 6:00 PM, EXPIRED PRODUCT ADMINISTERED (needed to re take second dose as punctured vial was open for more than six hours) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered EXPIRED PRODUCT ADMINISTERED (needed to re take second dose as punctured vial was open for more than six hours) to be not applicable.    The patient did not take any concomitant medication.  The patient did not experience any adverse event.   This case was linked to MOD-2021-015145, MOD-2021-075375, MOD-2021-075421, MOD-2021-075507 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Off label use
Clinical narrative: Second shot was not administered, the second dose within 36 days; This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (Second shot was not administered, the second dose within 36 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OFF LABEL USE (Second shot was not administered, the second dose within 36 days). At the time of the report, OFF LABEL USE (Second shot was not administered, the second dose within 36 days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Limb discomfort, Loss of personal independence in daily activities, Muscular weakness, Pain in extremity, Product administered at inappropriate site
Clinical narrative: can not fully lift my arm without pain/struggling to use my arm properly; Likely rotator cuff damage; Lost strength in the arm; SIRVA from my original injection; I am having trouble living normally now; Vaccine was injected incorrectly (too high and deep) for my first dose; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), LIMB DISCOMFORT (can not fully lift my arm without pain/struggling to use my arm properly), ROTATOR CUFF SYNDROME (Likely rotator cuff damage), MUSCULAR WEAKNESS (Lost strength in the arm) and SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (SIRVA from my original injection) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Vaccine was injected incorrectly (too high and deep) for my first dose). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain), LIMB DISCOMFORT (can not fully lift my arm without pain/struggling to use my arm properly), ROTATOR CUFF SYNDROME (Likely rotator cuff damage), MUSCULAR WEAKNESS (Lost strength in the arm), SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (SIRVA from my original injection) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I am having trouble living normally now). On 26-Feb-2021, PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Vaccine was injected incorrectly (too high and deep) for my first dose) had resolved. At the time of the report, PAIN IN EXTREMITY (arm pain), LIMB DISCOMFORT (can not fully lift my arm without pain/struggling to use my arm properly), ROTATOR CUFF SYNDROME (Likely rotator cuff damage), MUSCULAR WEAKNESS (Lost strength in the arm), SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (SIRVA from my original injection) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I am having trouble living normally now) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant product use was not provided by the reporter.  The patient had an MRI scheduled in few days (date unspecified). The patient was concerned for the effectiveness of the first dose. The patient stated that if the vaccine was injected incorrectly, into the subdeltoid bursa, or not in the muscle, the patient would not have a proper reaction and generate a defense.  Treatment medication information was not provided.   This case was linked to MOD-2021-075522 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Rotator cuff syndrome, Shoulder injury related to vaccine administration
Clinical narrative: can not fully lift my arm without pain/struggling to use my arm properly; Likely rotator cuff damage; Lost strength in the arm; SIRVA from my original injection; I am having trouble living normally now; Vaccine was injected incorrectly (too high and deep) for my first dose; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), LIMB DISCOMFORT (can not fully lift my arm without pain/struggling to use my arm properly), ROTATOR CUFF SYNDROME (Likely rotator cuff damage), MUSCULAR WEAKNESS (Lost strength in the arm) and SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (SIRVA from my original injection) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Vaccine was injected incorrectly (too high and deep) for my first dose). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain), LIMB DISCOMFORT (can not fully lift my arm without pain/struggling to use my arm properly), ROTATOR CUFF SYNDROME (Likely rotator cuff damage), MUSCULAR WEAKNESS (Lost strength in the arm), SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (SIRVA from my original injection) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I am having trouble living normally now). On 26-Feb-2021, PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Vaccine was injected incorrectly (too high and deep) for my first dose) had resolved. At the time of the report, PAIN IN EXTREMITY (arm pain), LIMB DISCOMFORT (can not fully lift my arm without pain/struggling to use my arm properly), ROTATOR CUFF SYNDROME (Likely rotator cuff damage), MUSCULAR WEAKNESS (Lost strength in the arm), SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (SIRVA from my original injection) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I am having trouble living normally now) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant product use was not provided by the reporter.  The patient had an MRI scheduled in few days (date unspecified). The patient was concerned for the effectiveness of the first dose. The patient stated that if the vaccine was injected incorrectly, into the subdeltoid bursa, or not in the muscle, the patient would not have a proper reaction and generate a defense.  Treatment medication information was not provided.   This case was linked to MOD-2021-075522 (Patient Link).
Age: 28.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Improperly handled vaccines; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Improperly handled vaccines) in a 28-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Improperly handled vaccines). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Improperly handled vaccines) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The clinic reporter works at was administering vaccines today. Yesterday morning at 8:30AM an individual drew up doses of vaccine from a vial and placed syringes loaded with doses vaccine into the refrigerator. Today those vaccines were administered. They were removed from the refrigerator as needed for administration. All vaccines were administered between 1:00 and 3:30 PM. This patient received their second dose of the vaccine by IM injection at 2:30 PM 13APR2021 (026B21A). They received their first dose of the vaccine by IM injection on 17MAR2021. They have had no known symptoms, and were observed for 15 minutes after administration of the second dose today.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headaches). At the time of the report, HEADACHE (Headaches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  The patient stated the many on her senior residence had the same headaches as her.  No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: developed bad headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (developed bad headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (developed bad headache). At the time of the report, HEADACHE (developed bad headache) had not resolved. Not Provided           No concomitant drugs and treatment medications were reported.  Patient received the 2nd dose and developed bad headache which has been 2months and won't go away. It been around the clock. Patient has been in ER and seen several specialists and all have proved futile.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Body temperature, Dizziness, Fatigue, Heart rate
Clinical narrative: Lightheadedness; Fatigue; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (Lightheadedness) and FATIGUE (Fatigue) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced DIZZINESS (Lightheadedness) and FATIGUE (Fatigue). At the time of the report, DIZZINESS (Lightheadedness) and FATIGUE (Fatigue) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Blood pressure measurement: 130/90 mmhg (High) at 17:45 pm. On 08-Apr-2021, Body temperature: 99.4 (normal) at 17:45 pm. On 08-Apr-2021, Heart rate (60-100): 70 (normal) at 17:45 pm. On 08-Apr-2021, Oxygen saturation (Unknown-100): 98 % (normal) at 17:45 pm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Patient laid down and was given juice to drink. And was monitored an additional 30 minutes and started feeling better. Treatment information was not provided..   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Additional information received and Route of Administration Intramuscular, Anatomical site of vaccination was updated to Left Deltoid
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation
Clinical narrative: Lightheadedness; Fatigue; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (Lightheadedness) and FATIGUE (Fatigue) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced DIZZINESS (Lightheadedness) and FATIGUE (Fatigue). At the time of the report, DIZZINESS (Lightheadedness) and FATIGUE (Fatigue) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Blood pressure measurement: 130/90 mmhg (High) at 17:45 pm. On 08-Apr-2021, Body temperature: 99.4 (normal) at 17:45 pm. On 08-Apr-2021, Heart rate (60-100): 70 (normal) at 17:45 pm. On 08-Apr-2021, Oxygen saturation (Unknown-100): 98 % (normal) at 17:45 pm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Patient laid down and was given juice to drink. And was monitored an additional 30 minutes and started feeling better. Treatment information was not provided..   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Additional information received and Route of Administration Intramuscular, Anatomical site of vaccination was updated to Left Deltoid
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: really horrible pain in her right leg primarily hip and knee; really horrible pain in her right leg primarily hip and knee; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (really horrible pain in her right leg primarily hip and knee) and ARTHRALGIA (really horrible pain in her right leg primarily hip and knee) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (really horrible pain in her right leg primarily hip and knee) and ARTHRALGIA (really horrible pain in her right leg primarily hip and knee). The patient was treated with PARACETAMOL (TYLENOL) for Pain in extremity, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (really horrible pain in her right leg primarily hip and knee) and ARTHRALGIA (really horrible pain in her right leg primarily hip and knee) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-075531 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075531:case for second dose
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: patient broke out in hives on his elbows, around his waits and thighs; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (patient broke out in hives on his elbows, around his waits and thighs) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     The patient's past medical history included Hives (as per patient he is prone to hives.).    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced URTICARIA (patient broke out in hives on his elbows, around his waits and thighs). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Hives, at an unspecified dose and frequency. On 22-Mar-2021, URTICARIA (patient broke out in hives on his elbows, around his waits and thighs) had resolved.  Treatment includes Benadryl.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Fatigue; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue). At the time of the report, PAIN IN EXTREMITY (Sore arm) had resolved and FATIGUE (Fatigue) outcome was unknown.            Concomitant product use was not provided by the reporter.  The patient was concerned that vaccination may not be properly completed.  Treatment medication information was not provided.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-075471 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Feeling cold, Nausea, Pyrexia
Clinical narrative: was cold; Diarrhea; Sleepy; Threw up once; was cold, mentioned that she she would sit on couch and shake; Mild fever; Rash at injection around site 2/ 3 inches; Nausea/ thought of eating was nauseating; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (was cold), DIARRHOEA (Diarrhea), SOMNOLENCE (Sleepy), VACCINATION SITE RASH (Rash at injection around site 2/ 3 inches) and NAUSEA (Nausea/ thought of eating was nauseating) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 03-Apr-2021, the patient experienced VACCINATION SITE RASH (Rash at injection around site 2/ 3 inches) and NAUSEA (Nausea/ thought of eating was nauseating). On an unknown date, the patient experienced FEELING COLD (was cold), DIARRHOEA (Diarrhea), SOMNOLENCE (Sleepy), VOMITING (Threw up once), CHILLS (was cold, mentioned that she she would sit on couch and shake) and PYREXIA (Mild fever). At the time of the report, FEELING COLD (was cold), DIARRHOEA (Diarrhea), SOMNOLENCE (Sleepy), VACCINATION SITE RASH (Rash at injection around site 2/ 3 inches), NAUSEA (Nausea/ thought of eating was nauseating), VOMITING (Threw up once), CHILLS (was cold, mentioned that she she would sit on couch and shake) and PYREXIA (Mild fever) outcome was unknown.            Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.      Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Non significant follow up appended.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence, Vaccination site rash, Vomiting
Clinical narrative: was cold; Diarrhea; Sleepy; Threw up once; was cold, mentioned that she she would sit on couch and shake; Mild fever; Rash at injection around site 2/ 3 inches; Nausea/ thought of eating was nauseating; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (was cold), DIARRHOEA (Diarrhea), SOMNOLENCE (Sleepy), VACCINATION SITE RASH (Rash at injection around site 2/ 3 inches) and NAUSEA (Nausea/ thought of eating was nauseating) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 03-Apr-2021, the patient experienced VACCINATION SITE RASH (Rash at injection around site 2/ 3 inches) and NAUSEA (Nausea/ thought of eating was nauseating). On an unknown date, the patient experienced FEELING COLD (was cold), DIARRHOEA (Diarrhea), SOMNOLENCE (Sleepy), VOMITING (Threw up once), CHILLS (was cold, mentioned that she she would sit on couch and shake) and PYREXIA (Mild fever). At the time of the report, FEELING COLD (was cold), DIARRHOEA (Diarrhea), SOMNOLENCE (Sleepy), VACCINATION SITE RASH (Rash at injection around site 2/ 3 inches), NAUSEA (Nausea/ thought of eating was nauseating), VOMITING (Threw up once), CHILLS (was cold, mentioned that she she would sit on couch and shake) and PYREXIA (Mild fever) outcome was unknown.            Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.      Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Non significant follow up appended.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dysstasia, Pain in extremity
Clinical narrative: really horrible pain in her right leg primarily hip and knee/escalated 10 times after the second shot; cannot get out of the bed without a walker; really horrible pain in her right leg primarily hip and knee; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (really horrible pain in her right leg primarily hip and knee/escalated 10 times after the second shot), DYSSTASIA (cannot get out of the bed without a walker) and ARTHRALGIA (really horrible pain in her right leg primarily hip and knee) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced PAIN IN EXTREMITY (really horrible pain in her right leg primarily hip and knee/escalated 10 times after the second shot), DYSSTASIA (cannot get out of the bed without a walker) and ARTHRALGIA (really horrible pain in her right leg primarily hip and knee). The patient was treated with TYLENOL for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (really horrible pain in her right leg primarily hip and knee/escalated 10 times after the second shot), DYSSTASIA (cannot get out of the bed without a walker) and ARTHRALGIA (really horrible pain in her right leg primarily hip and knee) outcome was unknown.            No concomitant and treatment medications were reported. For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable.    This case was linked to MOD-2021-075508.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Bartholin's cyst, Haematuria
Clinical narrative: Bartholin's cyst; Peeing blood / blood in her urine; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of BARTHOLIN'S CYST (Bartholin's cyst) and HAEMATURIA (Peeing blood / blood in her urine) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010a21a and 028l20a) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced BARTHOLIN'S CYST (Bartholin's cyst) and HAEMATURIA (Peeing blood / blood in her urine). In March 2021, BARTHOLIN'S CYST (Bartholin's cyst) and HAEMATURIA (Peeing blood / blood in her urine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No Treatment medications were reported. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-228268, MOD-2021-228268 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Urticaria, Vaccination site pain
Clinical narrative: Welts randomly pop up on her body/3 welts on the left arm/2 welts on right arm/; Right arm was sore at injection site; left arm was sore as well; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Welts randomly pop up on her body), VACCINATION SITE PAIN (Right arm was sore at injection site) and MYALGIA (left arm was sore as well) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030AZ1A and 040B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Allergy to antibiotic and Seasonal allergy. Concomitant products included LISINOPRIL, AMLODIPINE, ESTRADIOL, PANTOPRAZOLE, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and FLUTICASONE for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced URTICARIA (Welts randomly pop up on her body), VACCINATION SITE PAIN (Right arm was sore at injection site) and MYALGIA (left arm was sore as well). At the time of the report, URTICARIA (Welts randomly pop up on her body), VACCINATION SITE PAIN (Right arm was sore at injection site) and MYALGIA (left arm was sore as well) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-075554 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075554:linked to 2nd dose
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Large raised arm swelling 8 days post injection over injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE SWELLING (Large raised arm swelling 8 days post injection over injection site) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 011320A) for COVID-19 vaccination.     The patient's past medical history included Anal dilation procedure. Concurrent medical conditions included Ulcerative colitis and Drug allergy (Cipro, morphine and ibuprofen products). Concomitant products included LORATADINE (ALLERCLEAR) for Allergy, RAMIPRIL for Blood pressure management.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Feb-2021 at 8:00 AM, the patient experienced VACCINATION SITE SWELLING (Large raised arm swelling 8 days post injection over injection site). At the time of the report, VACCINATION SITE SWELLING (Large raised arm swelling 8 days post injection over injection site) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered VACCINATION SITE SWELLING (Large raised arm swelling 8 days post injection over injection site) to be possibly related.    This case was linked to MOD-2021-011942, MOD-2021-011942 (Patient Link).
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Gait disturbance, Headache
Clinical narrative: finding difficulty in walk; arm hurt very badly; she started having fever; chills; body ache; headache; joint pain; very tired with legs; arm joints very painful; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (finding difficulty in walk), PAIN IN EXTREMITY (arm hurt very badly), PYREXIA (she started having fever), CHILLS (chills) and MYALGIA (body ache) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced GAIT DISTURBANCE (finding difficulty in walk), PAIN IN EXTREMITY (arm hurt very badly), PYREXIA (she started having fever), CHILLS (chills), MYALGIA (body ache), HEADACHE (headache), ARTHRALGIA (joint pain), FATIGUE (very tired with legs) and ARTHRALGIA (arm joints very painful). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, GAIT DISTURBANCE (finding difficulty in walk), PAIN IN EXTREMITY (arm hurt very badly), PYREXIA (she started having fever), CHILLS (chills), MYALGIA (body ache), HEADACHE (headache), ARTHRALGIA (joint pain), FATIGUE (very tired with legs) and ARTHRALGIA (arm joints very painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had hormonal replacement treatment that are progesterone and estrogen.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity, Pyrexia
Clinical narrative: finding difficulty in walk; arm hurt very badly; she started having fever; chills; body ache; headache; joint pain; very tired with legs; arm joints very painful; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (finding difficulty in walk), PAIN IN EXTREMITY (arm hurt very badly), PYREXIA (she started having fever), CHILLS (chills) and MYALGIA (body ache) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced GAIT DISTURBANCE (finding difficulty in walk), PAIN IN EXTREMITY (arm hurt very badly), PYREXIA (she started having fever), CHILLS (chills), MYALGIA (body ache), HEADACHE (headache), ARTHRALGIA (joint pain), FATIGUE (very tired with legs) and ARTHRALGIA (arm joints very painful). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, GAIT DISTURBANCE (finding difficulty in walk), PAIN IN EXTREMITY (arm hurt very badly), PYREXIA (she started having fever), CHILLS (chills), MYALGIA (body ache), HEADACHE (headache), ARTHRALGIA (joint pain), FATIGUE (very tired with legs) and ARTHRALGIA (arm joints very painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had hormonal replacement treatment that are progesterone and estrogen.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: Arm was hurting; Face was swollen; Felt very tired/ not gotten out of the bed; Has a fever of 100 F; Has achiness in his muscles; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was hurting), SWELLING FACE (Face was swollen), FATIGUE (Felt very tired/ not gotten out of the bed), PYREXIA (Has a fever of 100 F) and MYALGIA (Has achiness in his muscles) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced PAIN IN EXTREMITY (Arm was hurting), SWELLING FACE (Face was swollen), FATIGUE (Felt very tired/ not gotten out of the bed), PYREXIA (Has a fever of 100 F) and MYALGIA (Has achiness in his muscles). At the time of the report, PAIN IN EXTREMITY (Arm was hurting), SWELLING FACE (Face was swollen), FATIGUE (Felt very tired/ not gotten out of the bed), PYREXIA (Has a fever of 100 F) and MYALGIA (Has achiness in his muscles) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Body temperature: 100 f (High) 100 F.         No concomitant medications reported.  No treatment information provided..
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Arm was hurting; Face was swollen; Felt very tired/ not gotten out of the bed; Has a fever of 100 F; Has achiness in his muscles; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was hurting), SWELLING FACE (Face was swollen), FATIGUE (Felt very tired/ not gotten out of the bed), PYREXIA (Has a fever of 100 F) and MYALGIA (Has achiness in his muscles) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced PAIN IN EXTREMITY (Arm was hurting), SWELLING FACE (Face was swollen), FATIGUE (Felt very tired/ not gotten out of the bed), PYREXIA (Has a fever of 100 F) and MYALGIA (Has achiness in his muscles). At the time of the report, PAIN IN EXTREMITY (Arm was hurting), SWELLING FACE (Face was swollen), FATIGUE (Felt very tired/ not gotten out of the bed), PYREXIA (Has a fever of 100 F) and MYALGIA (Has achiness in his muscles) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Body temperature: 100 f (High) 100 F.         No concomitant medications reported.  No treatment information provided..
Age: 59.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Pruritus, Urticaria
Clinical narrative: 2 welts on right arm, chest, stomach; all of them itch; This spontaneous case was reported by a patient and describes the occurrence of URTICARIA (2 welts on right arm, chest, stomach) and PRURITUS (all of them itch) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.    Co-suspect product included non-company product DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    Concurrent medical conditions included Hypertension, Drug allergy (Allergic to Biaxin.) and Seasonal allergy. Concomitant products included LISINOPRIL, AMLODIPINE, ESTRADIOL, PANTOPRAZOLE, ASPIRIN [ACETYLSALICYLIC ACID] and FLUTICASONE for an unknown indication.   On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (unknown route) at an unspecified dose. On 12-Apr-2021, the patient experienced URTICARIA (2 welts on right arm, chest, stomach) and PRURITUS (all of them itch). The patient was treated with CORTISONE at an unspecified dose and frequency. At the time of the report, URTICARIA (2 welts on right arm, chest, stomach) and PRURITUS (all of them itch) outcome was unknown.            This case was linked to US-MODERNATX, INC.-MOD-2021-075533 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075533:
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia, Injected limb mobility decreased, Pain, Pain in extremity
Clinical narrative: Sore arm/arm feels like its broken; Numb spots; Radiating pain all the way down to my fingers; I can't lift, I can't let my arm hang like normal; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm/arm feels like its broken), HYPOAESTHESIA (Numb spots), PAIN (Radiating pain all the way down to my fingers) and INJECTED LIMB MOBILITY DECREASED (I can't lift, I can't let my arm hang like normal) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm/arm feels like its broken), HYPOAESTHESIA (Numb spots), PAIN (Radiating pain all the way down to my fingers) and INJECTED LIMB MOBILITY DECREASED (I can't lift, I can't let my arm hang like normal). At the time of the report, PAIN IN EXTREMITY (Sore arm/arm feels like its broken), HYPOAESTHESIA (Numb spots), PAIN (Radiating pain all the way down to my fingers) and INJECTED LIMB MOBILITY DECREASED (I can't lift, I can't let my arm hang like normal) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided. No treatment information was provided.  Patient's second dose of the vaccine was scheduled on 21-Apr-2021.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nasopharyngitis, Pain in extremity, Vaccination site erythema, Vaccination site pain
Clinical narrative: Cold symptoms; Within hours injection site became red; injection site became red, itchy; n hours injection site became hot; hours injection site became red, itchy, hot and raised; Patient experienced injection site pain; connective tissue from elbow to wrist painful; fatigue; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Apr-2021 and was forwarded to Moderna on 12-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Within hours injection site became red), VACCINATION SITE PRURITUS (injection site became red, itchy), VACCINATION SITE WARMTH (n hours injection site became hot), VACCINATION SITE SWELLING (hours injection site became red, itchy, hot and raised) and VACCINATION SITE PAIN (Patient experienced injection site pain) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Latex allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) and TOFACITINIB CITRATE (XELJANZ) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (Within hours injection site became red), VACCINATION SITE PRURITUS (injection site became red, itchy), VACCINATION SITE WARMTH (n hours injection site became hot), VACCINATION SITE SWELLING (hours injection site became red, itchy, hot and raised), VACCINATION SITE PAIN (Patient experienced injection site pain), PAIN IN EXTREMITY (connective tissue from elbow to wrist painful) and FATIGUE (fatigue). On 10-Apr-2021, the patient experienced NASOPHARYNGITIS (Cold symptoms). On 04-Apr-2021, VACCINATION SITE PAIN (Patient experienced injection site pain) outcome was unknown, PAIN IN EXTREMITY (connective tissue from elbow to wrist painful) and FATIGUE (fatigue) had resolved. On 10-Apr-2021, NASOPHARYNGITIS (Cold symptoms) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Within hours injection site became red), VACCINATION SITE PRURITUS (injection site became red, itchy), VACCINATION SITE WARMTH (n hours injection site became hot) and VACCINATION SITE SWELLING (hours injection site became red, itchy, hot and raised) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient took Benadryl as treatment
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Cold symptoms; Within hours injection site became red; injection site became red, itchy; n hours injection site became hot; hours injection site became red, itchy, hot and raised; Patient experienced injection site pain; connective tissue from elbow to wrist painful; fatigue; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Apr-2021 and was forwarded to Moderna on 12-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Within hours injection site became red), VACCINATION SITE PRURITUS (injection site became red, itchy), VACCINATION SITE WARMTH (n hours injection site became hot), VACCINATION SITE SWELLING (hours injection site became red, itchy, hot and raised) and VACCINATION SITE PAIN (Patient experienced injection site pain) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Latex allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) and TOFACITINIB CITRATE (XELJANZ) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (Within hours injection site became red), VACCINATION SITE PRURITUS (injection site became red, itchy), VACCINATION SITE WARMTH (n hours injection site became hot), VACCINATION SITE SWELLING (hours injection site became red, itchy, hot and raised), VACCINATION SITE PAIN (Patient experienced injection site pain), PAIN IN EXTREMITY (connective tissue from elbow to wrist painful) and FATIGUE (fatigue). On 10-Apr-2021, the patient experienced NASOPHARYNGITIS (Cold symptoms). On 04-Apr-2021, VACCINATION SITE PAIN (Patient experienced injection site pain) outcome was unknown, PAIN IN EXTREMITY (connective tissue from elbow to wrist painful) and FATIGUE (fatigue) had resolved. On 10-Apr-2021, NASOPHARYNGITIS (Cold symptoms) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Within hours injection site became red), VACCINATION SITE PRURITUS (injection site became red, itchy), VACCINATION SITE WARMTH (n hours injection site became hot) and VACCINATION SITE SWELLING (hours injection site became red, itchy, hot and raised) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient took Benadryl as treatment